High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection
Amy L Sandul; Nwabunie Nwana; J Mike Holcombe; Mark N Lobato; Suzanne Marks; Risa Webb; Shu-Hua Wang; Brock Stewart; Phil Griffin; Garrett Hunt; Neha Shah; Asween Marco; Naveen Patil; Leonard Mukasa; Ruth N Moro; John Jereb; Sundari Mase; Terence Chorba; Sapna Bamrah-Morris; Christine S Ho
Author Information: Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.